Topical Mastic Oil for Treatment of  Functional Dyspepsia: A Randomized , Triple-Blind Controlled Trial

Sattarzadeh, Mahsa Baradaran; Shojaii, Asie; Toosi, Mohsen Nasiri; Abdollahifard, M; Avanaki, Foroogh Alborzi; Taher, Mohammad; Shiehmorteza, Maryam; Hashem-Dabaghian, Fataneh

doi:10.31661/gmj.v10i0.1965

Cited by 3 publications

(3 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…157 Topical mastic oil was examined in a triple-blind RCT in pregnant patients with pre-existing FD confirmed by endoscopy and other negative tests. 141 It was compared to topical sesame oil applied during massage alongside pantoprazole. While both interventions were successful in decreasing symptoms, topical mastic oil was significantly more in decreasing measures of early satiation.…”

Section: Herbal Therapiesmentioning

confidence: 99%

“…There is only one study 141 examining the effectiveness of herbal remedies within the pregnant FD population despite herbal remedies being a commonly used over‐the‐counter treatment for dyspepsia in the pregnant population (Table 1). 142 As a result, much of the evidence is in the general population.…”

Section: Management Of Pre‐existing Functional Dyspepsia In Pregnancymentioning

confidence: 99%

“…Topical mastic oil was examined in a triple‐blind RCT in pregnant patients with pre‐existing FD confirmed by endoscopy and other negative tests 141 . It was compared to topical sesame oil applied during massage alongside pantoprazole.…”

Section: Management Of Pre‐existing Functional Dyspepsia In Pregnancymentioning

confidence: 99%

See 2 more Smart Citations

Review article: Functional dyspepsia and pregnancy—Effects and management in a special population

Liu

Starkey

Virani

et al. 2023

Aliment Pharmacol Ther

View full text Add to dashboard Cite

Background: Around 10% of Americans meet the Rome IV criteria for functional dyspepsia (FD), with a significantly higher rate in women. FD also has a higher prevalence in women below the age of 50, suggesting that women who are affected are likely to be of reproductive age. Unfortunately, there is a lack of research or evidence-based guidelines on managing FD in pregnancy. Aims and Methods:To address this issue, we aimed to perform a systematic review of the interactions between FD and pregnancy and managing pre-existing FD in the peripartum and post-partum phases using current lifestyle, pharmacological, nonpharmacological and alternative medicine interventions. Results: Due to the lack of Rome IV FD-specific data in pregnancy, we instead performed a narrative review on how existing FD interventions could be extrapolated to the pregnant population. Where possible we use the highest level of available evidence or official guidelines to answer these questions, which often involves synthesising treatment and safety evidence of these interventions in other diseases during pregnancy. Finally, we highlight current substantial knowledge gaps requiring further research for the safe management of a pregnant patient with pre-existing FD. Conclusions: Overall, despite the paucity of knowledge of treating FD during pregnancy, providers can mitigate this uncertainty by planning ahead with the patient. Patients should ideally minimise treatment until after breastfeeding. However, interdisciplinary resources are available to ensure that minimal-risk interventions are maximised, while interventions with more risks, if necessary, are justifiable by both the patient and the care team. Future investigations should continue to elicit the mechanistic relationship between FD and pregnancy while cautiously expanding prospective research on promising and safe therapies in pregnant patients with preexisting FD.

show abstract

Section: Herbal Therapiesmentioning

confidence: 99%

Section: Management Of Pre‐existing Functional Dyspepsia In Pregnancymentioning

confidence: 99%